Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina - Takeaways - MDSpire

Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina

  • By

  • Analisa Manin

  • Fernanda Ingenito

  • Evangelina Valeria Cores

  • Diego Alarcón Guerrero

  • Silvia Graciela Ramos

  • Andrés M. Villa

  • May 29, 2026

  • 0 min

Share

  • 1

    The study evaluated the κ-FLC index's diagnostic performance for multiple sclerosis (MS) in a cohort of patients with various neurological disorders.

  • 2

    A total of 124 patients were included, with significant differences in median κ-FLC index values between MS/CIS, other inflammatory, and non-inflammatory disorders.

  • 3

    The optimal κ-FLC index cut-off for distinguishing MS/CIS from other inflammatory diseases was found to be 14.6, with a sensitivity of 73.5%.

  • 4

    Reiber’s diagram for κ-FLC synthesis showed the highest sensitivity at 91.8%, although with lower specificity compared to higher κ-FLC index thresholds.

  • 5

    The findings suggest that higher κ-FLC index thresholds may enhance diagnostic specificity for MS and warrant validation in independent studies.

Original Source(s)

Related Content